天堂国产一区二区三区丨好湿好紧太硬了我太爽了视频丨日本高清视频在线www色丨免费人成视频丨边喂奶边中出的人妻

產品詳情
  • 產品名稱:Anti-GIRK1/KCNJ3抗體

  • 產品型號:G蛋白激活內向鉀通道1抗體
  • 產品廠商:KALANG
  • 產品文檔:
你添加了1件商品 查看購物車
簡單介紹:
Anti-GIRK1/KCNJ3抗體產品質量穩定,實驗效果明顯,貨期快,價格優惠,歡迎垂詢訂購!我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-GIRK1/KCNJ3抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹:
Rabbit  Anti-GIRK1/KCNJ3
Cat. Number:
Anti-GIRK1/KCNJ3抗體KL-6672R
Quantity size:
0.2ml
Concentration:
1mg/ml   Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
This potassium channel is controlled by G proteins. Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated Anti-GIRK1/KCNJ3抗體by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium. This receptor plays a crucial role in regulating the heartbeat.
Also known as:
inwardly rectifying subfamily J member 3; Anti-GIRK1/KCNJ3抗體G protein activated inward rectifier potassium channel 1; G protein-activated inward rectifier potassium channel 1; GIRK-1; Inward rectifier K(+) channel Kir3.1; Inwardly rectifying potassium channel KIR3.1; IRK3; IRK3_HUMAN; Kcnf3; Kcnj3; KGA; KGB1; Kir3.1; Potassium channel; Potassium channel, inwardly rectifying subfamily J member 3; Potassium inwardly-rectifying channel, subfamily J, member 3.
Specificity:
Rabbit Polyclonal IgG, affinity purified by Protein A.
Reacts with: Human, Mouse, Rat, Dog,Anti-GIRK1/KCNJ3抗體 Pig, Cow, Rabbit, Guinea Pig, .
Immunogen: KLH conjugated synthetic peptide derived from human GIRK1.
Predicted Molecular Weight: 55kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  IF=1:100-500   
Not yet tested in other applications. Anti-GIRK1/KCNJ3抗體
Optimal working dilutions must be determined by the end user.
kl650Hu01 主要堿性蛋白(MBP)多克隆抗體 Polyclonal Antibody to Major Basic Protein (MBP)
kl650Mu01 主要堿性蛋白(MBP)多克隆抗體 Polyclonal Antibody to Major Basic Protein (MBP)
kl650Ra01 主要堿性蛋白(MBP)多克隆抗體 Polyclonal Antibody to Major Basic Protein (MBP)
kl650Po01 主要堿性蛋白(MBP)多克隆抗體 Polyclonal Antibody to Major Basic Protein (MBP)
kl908Ge01 褪黑素(MT)多克隆抗體 Polyclonal Antibody to Melatonin (MT)
kl575Hu01 胃動素(MTL)多克隆抗體 Polyclonal Antibody to Motilin (MTL)
kl575Ra01 胃動素(MTL)多克隆抗體 Polyclonal Antibody to Motilin (MTL)
kl575Rb51 胃動素(MTL)多克隆抗體 Polyclonal Antibody to Motilin (MTL)
kl575Bo01 胃動素(MTL)多克隆抗體 Polyclonal Antibody to Motilin (MTL)
kl095Hu01 粘蛋白(MUC)多克隆抗體 Polyclonal Antibody to Mucin (MUC)
kl095Po01 粘蛋白(MUC)多克隆抗體 Polyclonal Antibody to Mucin (MUC)
kl480Ca01 肌紅蛋白(MYO)多克隆抗體 Polyclonal Antibody to Myoglobin (MYO)
kl480Ga01 肌紅蛋白(MYO)多克隆抗體 Polyclonal Antibody to Myoglobin (MYO)
kl098Hu01 肌漿球蛋白(Myo)多克隆抗體 Polyclonal Antibody to Myosin(Myo)
kl098Rb51 肌漿球蛋白(Myo)多克隆抗體 Polyclonal Antibody to Myosin(Myo)
kl218Ge01 **脫落酸(ABA)多克隆抗體 Polyclonal Antibody to Abscisic Acid (ABA)
kl907Ge01 去甲腎上腺素(NE)多克隆抗體 Polyclonal Antibody to Noradrenaline (NE)
kl121Ge01 **肽(OP)多克隆抗體 Polyclonal Antibody to Opioid Peptide (OP)
kl115Pl01 多酚氧化酶(PPO)多克隆抗體 Polyclonal Antibody to Polyphenol Oxidase (PPO)

標題:
內容:
聯系人:
聯系電話:
Email:
公司名稱:
聯系地址:
 
 
注:1.可以使用快捷鍵Alt+S或Ctrl+Enter發送信息!
2.如有必要,請您留下您的詳細聯系方式!

滬公網安備 31011702004399號

主站蜘蛛池模板: 国产一区二区三区免费观看在线 | 中日韩va无码中文字幕| 日本一区二区三区免费播放| 国产成人无码精品亚洲| 动漫av网站免费观看| 成在人线av无码免费看| 4480yy私人精品国产| 欧美自拍另类欧美综合图片区| 国精产品999国精产品官网| 国产网红主播无码精品| 秋霞av在线露丝片av无码| 国内精品2020情侣视频| 国产综合久久久久久鬼色| 忍不住的亲子中文字幕| 永久免费无码成人网站| 国语自产视频在线| 国语自产偷拍精品视频偷| 国产午国产午夜精华 免费| 国产又色又爽又黄的在线观看视频 | 日本老妇人乱xxy| 亚洲精品一品区二品区三区| 无码啪啪熟妇人妻区| 国产精品久久久久无码av| 亚洲人成网站观看在线播放| 国产午夜福利在线播放87| 中文字幕一区二区三区乱码 | 国产97在线 | 日韩| 国产在线码观看清码视频| 亚洲精品中文字幕| 99精品人妻无码专区在线视频区| 精品国产一区二区三区四区精华液| 女上男下啪啪激烈高潮无遮盖| 96国产xxxx免费视频| 狠狠色综合网站久久久久久久高清| 亚洲一区日韩高清中文字幕亚洲| 综合 欧美 小说 另类 图| 日日天干夜夜狠狠爱| 无码av天天av天天爽| 爆乳一区二区三区无码| 嫩草av久久伊人妇女超级a| 日本久久久久久久做爰片日本|